Transport numbers in transdermal iontophoresis

Biophysical Journal

Volumn 90, Issue 8, 2006, Pages 2822-2830

  Mudry, Blaise ^a   Guy, Richard H ^a,b   Delgado Charro, M Begoña ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CHLORIDE; ION;

ANIMAL TISSUE; ARTICLE; CATION TRANSPORT; CONTROLLED STUDY; IN VITRO STUDY; ION TRANSPORT; IONTOPHORESIS; MAMMAL; NONHUMAN; SKIN;

ANIMALIA; MAMMALIA;

EID: 33645225108     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.105.074609     Document Type: Article

References (40)

1. Sage, B. H., and J. E. Riviere. 1992. Model systems in iontophoresis: transport efficacy. Adv. Drug Deliv. Rev. 9:265-287.
2. Delgado-Charro, M. B., and R. H. Guy. 2001. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. STP Pharma Sci. 11:403-414.
3. Singh, P., P. Liu, and S. M. Dinh. 2002. Facilitated transdermal delivery by iontophoresis. In Topical Absorption of Dermatological Products. R. L. Bronaugh and H. I. Maibach, editors. Marcel Dekker, New-York. 353-376.
4. Kalia, Y. N., A. Naik, J. Garrison, and R. H. Guy. 2004. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56:619-658.
5. Tierney, M. J., J. A. Tamada, R. O. Potts, R. C. Eastman, K. R. Pitzer, N. R. Ackerman, and S. Fermi. 2000. The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor. Ann. Med. 32:632-641.
6. Tierney, M. J., J. A. Tamada, R. O. Potts, L. Jovanovic, and S. Garg, and Cygnus Research Team. 2001. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens. Bioelectron. 16:621-629.
7. Leboulanger, B., R. H. Guy, and M. B. Delgado-Charro. 2004. Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Pharm. Res. 21:1214-1222.
8. Leboulanger, B., R. H. Guy, and M. B. Delgado-Charro. 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol. Meas. 25:R35-R50.
9. Burnette, R. R. 1989. Iontophoresis. In Transdermal Delivery Systems: Developmental Issues and Research Initiatives. J. Hadgraft and R. H. Guy, editors. Marcel Dekker, New York. 247-291.
10. Phipps, J. B., and G. Gyory. 1992. Transdermal ion migration. Adv. Drug Deliv. Rev. 9:137-176.
11. Clemessy, M., G. Couarraze, B. Bevan, and F. Puisieux. 1995. Mechanisms involved in iontophoretic transport of angiotensin. Pharm. Res. 12:998-1002.
12. Thysman, S., V. Preat, and M. Roland. 1992. Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 81:670-675.
13. Lopez, R. F. V., M. V. L. B. Bentley, M. B. Delgado-Charro, and R. H. Guy. 2003. Optimization of aminolevulinic acid delivery by iontophoresis. J. Controlled Release. 88:65-70.
14. Laksminarayanaiah, N. N. 1969. Transport Phenomena in Membranes. Academic Press, New York and London.
15. Luzardo-Alvarez, A., M. Rodríguez-Fernández, J. Blanco-Méndez, R. H. Guy, and M. B. Delgado-Charro. 1998. Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models. Pharm. Res. 15:984-987.
16. Marro, D., Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. 2001. Optimizing drug delivery: identification and distribution of the charge-carrying species. Pharm. Res. 18:1709-1713.
17. Kasting, G. B., and J. C. Keister. 1989. Application of electrodiffusion theory for a homogenous membrane to iontophoretic transport through skin. J. Controlled Release. 8:195-210.
18. Padmanabhan, R. V., J. B. Phipps, G. A. Lattin, and R. J. Sawchuk. 1990. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J. Controlled Release. 11:123-135.
19. Luzardo-Alvarez, A., M. B. Delgado-Charro, and J. Blanco-Méndez. 2001. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharm. Res. 18:1714-1720.
20. Luzardo-Alvarez, A., M. B. Delgado-Charro, and J. Blanco-Méndez. 2003. In vivo iontophoretic administration of ropinirole hydrochloride. J. Pharm. Sci. 92:2441-2448.
21. Roberts, M. S., P. M. Lai, and Y. G. Anissimov. 1998. Epidermal iontophoresis 1. Development of the ionic mobility-pore model. Pharm. Res. 15:1569-1578.
22. Lai, M. P., and M. S. Roberts. 1998. Epidermal iontophoresis 2. Application of the ionic mobility-pore model to the transport of local anaesthetics. Pharm. Res. 15:1579-1588.
23. Burnette, R. R., and B. Onpipattanakul. 1987. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:765-773.
24. Pikal, M. J., and S. Shah. 1990. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurement for hairless mouse skin. Pharm. Res. 7:213-221.
25. Glikfeld, P., R. S. Hinz, and R. H. Guy. 1989. Noninvasive sampling of biological fluids by iontophoresis. Pharm. Res. 6:988-990.
26. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2003. Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept. J. Pharm. Sci. 92:2295-2302.
27. Turner, N. G., and R. H. Guy. 1997. Iontophoretic transport pathways: Dependence on penetrant physicochemical pathways. J. Pharm. Sci. 86:1385-1389.
28. Delgado-Charro, M. B., and R. H. Guy. 2003. Transdermal reverse iontophoresis of valproate: A non-invasive tool for therapeutic drug monitoring. Pharm. Res. 20:1508-1513.
29. Leboulanger, B., J. M. Aubry, G. Gondolfi, R. H. Guy, and M. B. Delgado-Charro. 2004. Non-invasive lithium monitoring by reverse iontophoresis in vivo. Clin. Chem. 50:2091-2100.
30. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2004. Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring. Biophys. J. 87:3344-3350.
31. Falk, K. G. 1929. Transference numbers of electrolytes in aqueous solution. In International Critical Tables of Numerical Data, Physics, Chemistry and Technology, Vol. VI. E. W. Washburn, editor. McGraw-Hill, New York. 309-311.
32. Atkins, P. W. 1978. Molecules in motion: ion transport and molecular diffusion. In Physical Chemistry. P. W. Atkins, editor. Oxford University Press. Oxford, UK. 819-848.
33. Kasting, G. B., and L. A. Bowman. 1990. DC electrical properties of frozen, excised human skin. Pharm. Res. 7:134-143.
34. Marro, D., R. H. Guy, and M. B. Delgado-Charro. 2001. Characterization of the iontophoretic permselectivity properties of human skin and pig skin. J. Controlled Release. 70:213-217.
35. Green, P. G., R. S. Hinz, C. Cullander, G. Yamane, and R. H. Guy. 1991. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1113-1120.
36. Merino, V., A. López, Y. N. Kalia, and R. H. Guy. 1999. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16:758-761.
37. Kalia, Y. N., F. Pirot, R. O. Potts, and R. H. Guy. 1998. Ion mobility across human stratum corneum in vivo. J. Pharm. Sci. 87:1508-1511.
38. Lentner, C. 1984. Geigy Scientific Tables. Ciba Geigy, Basel, Switzerland.
39. Sieg, A., R. H. Guy, and M. B. Delgado-Charro. 2004. Non-invasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin. Chem. 50:1383-1390.
40. Marro, D., Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. 2001. Contribution of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18:1701-1709.